Instituto Nacional de Ciencias Medicas y Nutrición Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2015
NCT02923336
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

ALDO TORRE DELGADILLO | Instituto Nacional de Ciencias Medicas y Nutrición

Active Ingredients

Drugs in Phase 4 Trials (2)

isoniazid (nydrazid) (1 trial)

rifampin (1 trial)

Drugs in Other Trials (1)

propranolol (inderal) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3